id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-N-0323-0156,FDA,FDA-2002-N-0323,"Meeting Held in Fresno California on March 4, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:25:27Z,,0,0,09000064804a0b31
FDA-2002-N-0323-0154,FDA,FDA-2002-N-0323,List of FDA Domestic Outreach Meetings,Other,LST-List,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:25:29Z,,0,0,09000064804a0b2f
FDA-2002-N-0323-0158,FDA,FDA-2002-N-0323,"Meeting held in Salt Lake City, Utah on March 11, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:25:21Z,,0,0,09000064804a0b33
FDA-2002-N-0323-0151,FDA,FDA-2002-N-0323,Downlink Attendance Sheet,Other,LST-List,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:25:27Z,,0,0,09000064804a0b2c
FDA-2002-N-0323-0152,FDA,FDA-2002-N-0323,Bioterrorism Act Seminar Attendance Sheet,Other,LST-List,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:25:24Z,,0,0,09000064804a0b2d
FDA-2002-N-0323-0159,FDA,FDA-2002-N-0323,"Meeting held in Kansas City Missouri on March 16, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:25:16Z,,0,0,09000064804a0b34
FDA-2002-N-0323-0155,FDA,FDA-2002-N-0323,"Meeting Held in Denver Colorado on March 2, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:25:32Z,,0,0,09000064804a0b30
FDA-2002-N-0323-0162,FDA,FDA-2002-N-0323,"Meeting held in Boston, Massachusetts on April 1, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:25:21Z,,0,0,09000064804a0b38
FDA-2002-N-0323-0160,FDA,FDA-2002-N-0323,"Meeting held in New Orleans, Louisiana on March 18, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:25:27Z,,0,0,09000064804a0b36
FDA-2002-N-0323-0153,FDA,FDA-2002-N-0323,Bioterrorism Act Seminar Attendance Sheet,Other,LST-List,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:25:16Z,,0,0,09000064804a0b2e
FDA-2002-N-0323-0157,FDA,FDA-2002-N-0323,"Meeting held in El Paso Texas on March 9, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:25:32Z,,0,0,09000064804a0b32
FDA-2002-N-0323-0161,FDA,FDA-2002-N-0323,"Meeting held in Philadelphia, Pennsylvania on March 24, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:25:29Z,,0,0,09000064804a0b37
FDA-2002-N-0323-0150,FDA,FDA-2002-N-0323,FDA,Notice,NCR-Notice of Correction,2004-05-25T04:00:00Z,2004,5,2004-05-21T04:00:00Z,,2008-04-12T01:25:21Z,,0,0,09000064804a0b28
FDA-2002-N-0323-0118,FDA,FDA-2002-N-0323,FDA,Notice,NEC-Notice of Extension,2004-04-16T04:00:00Z,2004,4,2004-04-09T04:00:00Z,,2008-04-12T01:25:17Z,,0,0,09000064804a0aa4
FDA-2002-N-0323-0115,FDA,FDA-2002-N-0323,New FDA Bioterrorism Act Registration and Prior Notice Interim Final Rules,Other,TR-Transcript,2004-03-01T05:00:00Z,2004,3,,,2008-04-12T01:25:25Z,,0,0,09000064804a0a9d
FDA-2002-N-0323-0113,FDA,FDA-2002-N-0323,New FDA Bioterrorism Act Registration and Prior Notice Interim Final Rules,Other,TR-Transcript,2004-03-01T05:00:00Z,2004,3,,,2008-04-12T01:25:31Z,,0,0,09000064804a0a9b
FDA-2002-N-0323-0116,FDA,FDA-2002-N-0323,New FDA Bioterrorism Act Registration and Prior Notice Interim Final Rules,Other,TR-Transcript,2004-03-01T05:00:00Z,2004,3,,,2008-04-12T01:25:31Z,,0,0,09000064804a0a9e
FDA-2002-N-0323-0114,FDA,FDA-2002-N-0323,New FDA Bioterrorism Act Registration and Prior Notice Interim Final Rules,Other,TR-Transcript,2004-03-01T05:00:00Z,2004,3,,,2008-04-12T01:25:14Z,,0,0,09000064804a0a9c
FDA-2002-N-0323-0111,FDA,FDA-2002-N-0323,New FDA Bioterrorism Act Registration and Prior Notice Interim Final Rules,Other,TR-Transcript,2004-03-01T05:00:00Z,2004,3,,,2008-04-12T01:25:25Z,,0,0,09000064804a0a99
FDA-2002-N-0323-0112,FDA,FDA-2002-N-0323,New FDA Bioterrorism Act Registration and Prior Notice Interim Final Rules,Other,TR-Transcript,2004-03-01T05:00:00Z,2004,3,,,2008-04-12T01:25:28Z,,0,0,09000064804a0a9a
FDA-2002-N-0323-0107,FDA,FDA-2002-N-0323,See: FDA-2002-N-0323-0164,Supporting & Related Material,REF-Reference (internal unless indicated),2004-01-29T05:00:00Z,2004,1,,,2009-10-30T16:05:58Z,,0,0,09000064804a0a91
FDA-2002-N-0323-0110,FDA,FDA-2002-N-0323,See: FDA-2002-N-0323-0164,Supporting & Related Material,REF-Reference (internal unless indicated),2004-01-29T05:00:00Z,2004,1,,,2009-10-30T16:07:21Z,,0,0,09000064804a0a95
FDA-2002-N-0323-0106,FDA,FDA-2002-N-0323,See: FDA-2002-N-0323-0164,Supporting & Related Material,REF-Reference (internal unless indicated),2004-01-29T05:00:00Z,2004,1,,,2009-10-30T16:05:26Z,,0,0,09000064804a0a90
FDA-2002-N-0323-0105,FDA,FDA-2002-N-0323,See: FDA-2002-N-0323-0164,Supporting & Related Material,REF-Reference (internal unless indicated),2004-01-29T05:00:00Z,2004,1,,,2009-10-30T16:05:02Z,,0,0,09000064804a0a8f
FDA-2002-N-0323-0104,FDA,FDA-2002-N-0323,See: FDA-2002-N-0323-0164,Supporting & Related Material,REF-Reference (internal unless indicated),2004-01-29T05:00:00Z,2004,1,,,2009-10-30T16:04:27Z,,0,0,09000064804a0a8e
FDA-2002-N-0323-0108,FDA,FDA-2002-N-0323,See: FDA-2002-N-0323-0164,Supporting & Related Material,REF-Reference (internal unless indicated),2004-01-29T05:00:00Z,2004,1,,,2009-10-30T16:06:27Z,,0,0,09000064804a0a92
FDA-2002-N-0323-0109,FDA,FDA-2002-N-0323,See: FDA-2002-N-0323-0164,Supporting & Related Material,REF-Reference (internal unless indicated),2004-01-29T05:00:00Z,2004,1,,,2009-10-30T16:06:52Z,,0,0,09000064804a0a93
FDA-2002-N-0323-0103,FDA,FDA-2002-N-0323,FDA,Notice,NCR-Notice of Correction,2004-01-08T05:00:00Z,2004,1,2004-01-06T05:00:00Z,,2008-04-12T01:25:19Z,,0,0,09000064804a0a88